Disposition · Activity not yet classified
Cytovance Biologics
Transaction overview
Reported completed
Exact closing date not established.
On October 5, 2015, Great Point Partners reported that GPP I portfolio company Cytovance Biologics had been acquired by Hepalink USA. The release did not specify the exact closing date.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- Great Point Partners I Portfolio Company, Cytovance Biologics, Is Acquired by Hepalink USA - Great Point Partners ↗
Great Point Partners · Published Oct 5, 2015
On October 5, 2015, Great Point Partners reported that GPP I portfolio company Cytovance Biologics had been acquired by Hepalink USA. The release did not specify the exact closing date.